Previous Article | Next Article ![]()
Infection and Immunity, June 2001, p. 3939-3946, Vol. 69, No. 6
Laboratory of
Biophysics1 and Laboratory of
Immunology,2 School of Biological Sciences
and Institute of Microbiology, Seoul National University, Seoul
151-742, Republic of Korea
Received 14 November 2000/Returned for modification 11 December
2000/Accepted 19 March 2001
In some lower eukaryotes, D-erythroascorbic acid, a
five-carbon analog of L-ascorbic acid, is present instead
of L-ascorbic acid. We have cloned ALO1, the
gene encoding D-arabinono-1,4-lactone oxidase, which
catalyzes the final step of D-erythroascorbic acid biosynthesis in Candida albicans. The ALO1 gene
contained a continuous open reading frame of 1,671 bp that encodes a
polypeptide consisting of 557 amino acids with a calculated molecular
mass of 63,428 Da. To investigate the functional roles of
D-erythroascorbic acid in C. albicans, we
disrupted or overexpressed the ALO1 gene. In the
alo1/alo1 null mutants, the activity of
D-arabinono-1,4-lactone oxidase was completely lost and
D-erythroascorbic acid could not be detected. When
ALO1 on a multicopy plasmid was transformed in
C. albicans, the enzyme activity and the intracellular
D-erythroascorbic acid level were increased up to 3.4-fold
and 4.0-fold, respectively. The alo1/alo1 null mutants of
C. albicans showed increased sensitivity towards oxidative
stress. Overexpression of ALO1 made the cells more
resistant to the same stress. The alo1/alo1 mutants showed defective hyphal growth and attenuated virulence. Taken together, our
results suggest that D-erythroascorbic acid functions as an important antioxidant and can be considered one of the virulence factors enhancing the pathogenicity of C. albicans.
L-Ascorbic acid (ASC) is
produced in all higher plants and in nearly all higher animals except
human, other primates, guinea pig, some birds, and fish (1,
3). In animals, a microsomal L-gulono-1,4-lactone
oxidase catalyzes the final step of ASC biosynthesis (15,
29). Koshizaka et al. (17) isolated and
characterized a cDNA encoding L-gulono-1,4-lactone oxidase
from rat liver. Recently, a biosynthetic pathway for ASC involving
L-galactose and L-galactono-1,4-lactone in
plants has been proposed (39). It is believed in plants
that the final step of ASC biosynthesis is catalyzed by
L-galactono-1,4-lactone dehydrogenase (25,
30). The cDNAs encoding L-galactono-1,4-lactone dehydrogenase in cauliflower (31) and sweet potato
(11) have been isolated and analyzed. In some eukaryotic
microorganisms, ASC is rare or absent but D-erythroascorbic
acid (EASC), a five-carbon analog of ASC, is present (5, 24, 27,
28). In Candida albicans and Saccharomyces
cerevisiae, the biosynthetic pathway of EASC from
D-arabinose by D-arabinose dehydrogenase and
D-arabinono-1,4-lactone oxidase (ALO) has been established
(9, 10, 13, 14). ALO can also catalyze the production of
ASC when L-galactono-1,4-lactone is supplied as a substrate
(20).
ASC is known to carry out a number of biochemical functions that are a
consequence of its ability to donate one or two electrons. Some known
or proposed functions of ASC include its utilization as a free radical
scavenger, a cofactor for a number of enzymes, and a controlling factor
in plant cell development (26). However, many other
functions of the ASC system as well as the precise mechanisms of its
functions are still elusive. According to Shao et al.
(33), EASC is almost as readily oxidized as ASC in an aqueous system and has reducing power similar to that of ASC. In a
bioassay using tobacco hornworm (Manduca sexta) to
determine the vitamin C activity of EASC, EASC supported the larval
growth of the hornworm almost as well as ASC. This report suggests that EASC has biological properties similar to those of ASC. Considering that some eukaryotic microorganisms produce EASC instead of ASC, it is
presumed that EASC may take the place of ASC in these microorganisms. In our previous study, EASC has been proved an important antioxidant molecule in S. cerevisiae (10), like ASC in
animals and plants.
C. albicans is a well-known opportunistic fungal pathogen of
humans that does not usually cause disease in immunocompetent hosts but
causes serious diseases in immunocompromised patients. A number of
factors have been implicated to be associated with the virulence
properties of C. albicans, such as adhesion to the host
tissues, secretion of proteases, and reversible morphological transitions between yeasts, pseudohyphae, and hyphae (4).
Recent studies have led to the identification of several genes involved in the transition from yeast-like growth to hyphal growth in C. albicans. Deletion of the Candida genes in a MAPK
pathway, such as CST20, HST7, and CPHl, results
in impairment of the ability to make hyphae under some conditions,
albeit not in response to serum (16, 19, 22), suggesting
that there is more than one pathway controlling hyphal growth. Another
gene, EFG1, a homolog of S. cerevisiae PHD1, has
been found in C. albicans, and its reduced expression causes
loss of hyphal growth (36). The cphl/cphl efgl/efgl double mutants of C. albicans are unable to
form hyphae under almost all laboratory conditions tested and are
avirulent in a mouse model (23). These studies demonstrate
the importance of the transition from yeast-like to hyphal growth in
the virulence of C. albicans. The ability to adhere to the
host tissues has been also proved important in the pathogenicity of
C. albicans. Recently, Int1p, a surface protein with limited
similarity to vertebrate integrins, has been found in C. albicans. Disruption of INT1 in C. albicans
suppresses hyphal growth, adhesion to epithelial cells, and virulence
in mice (8). Another hypha-specific surface protein,
Hwplp, with similarities to small mammalian proline-rich proteins, has
been found in C. albicans and shown to serve as a substrate
for mammalian transglutaminases. The hwpl/hwpl mutants of
C. albicans are unable to form stable attachments to human buccal epithelial cells and have a reduced capacity to cause systemic candidiasis in mice (35).
To fully understand the pathogenicity of C. albicans,
survival traits should also be taken into consideration, in addition to
virulence traits. Survival indicates the ability of C. albicans to defend itself against the host immune system and grow
in the host successfully. In the present study, we describe the
isolation and characterization of the gene encoding ALO
(ALO1), which catalyzes the final step of EASC biosynthesis
in C. albicans. We show that EASC serves as an important
antioxidant, contributes to hyphal growth, and is essential for
C. albicans to exhibit full virulence, presumably by
enhancing survival of the organism in the host.
Yeast strains and culture conditions.
C. albicans
strains used in this study are listed in Table
1. The strains were routinely cultured on
YPD medium (1% yeast extract, 2% peptone, and 2% glucose) at 28°C.
Cells containing plasmids or disrupted genes were cultured in minimal
defined medium containing 0.67% yeast nitrogen base without amino
acids (Difco), 2% glucose, and appropriate supplements
(34). Solid media were prepared by adding 1.8% agar to
liquid broth. To assess filamentation on solid media, 104
cells in 2 µl of water were spotted onto the plates and incubated for
3 to 4 days.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3939-3946.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Deficiency of D-Erythroascorbic Acid
Attenuates Hyphal Growth and Virulence of Candida
albicans
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
C. albicans strains used in this study
Isolation, subcloning, and sequencing of ALO1 from
C. albicans.
To construct a C. albicans
genomic library, the genomic DNA from C. albicans ATCC 10231 was partially digested with Sau3AI and DNA fragments of 10 to 23 kb were ligated into dephosphorylated
EMBL3 vector
(Stratagene) generated by BamHI cleavage. The ligated DNA
was packaged using Gigapack II packaging extracts (Stratagene) and
replicated according to the manufacturer's instructions. Then, degenerate oligonucleotide primers corresponding to residues 52 to 58 (VGSGHSP) and 444 to 450 (GGKPHWA) of S. cerevisiae ALO1 (10) were synthesized:
5'-GTTGGTTCYGGCCAYTCYCC-3' and
5'-GGCCCARTGTGGCTTACCTCC-3', respectively, where Y
represents C or T and R represents A or G. PCR amplification was
carried out using the genomic DNA from C. albicans ATCC
10231 as a template under the following conditions: denaturation at
94°C for 1 min, annealing at 50°C for 1 min, and extension at
72°C for 2 min. Among the amplified DNA products, a DNA fragment of
1,359 bp was cloned into pGEM-T vector (Promega). The insert DNA
fragment was labeled with digoxigenin (Roche Molecular Biochemicals)
and used as a probe to screen the
EMBL3 genomic library. Four
positive clones were selected, and the common 3.8-kb HindIII fragment giving a positive signal was isolated
and cloned into pGEM-7Zf(+) (Promega) at the HindIII
site, yielding pCALO. Both stands of the cloned DNA were sequenced by
dideoxy chain termination method with an automatic sequencer
(ALFexpress; Amersham Pharmacia Biotech).
Disruption, overexpression, and reintegration of C. albicans ALO1.
Both alleles of ALO1 were
disrupted by using the URA blaster technique (6). A 4.1-kb
fragment containing the hisG-URA3-hisG gene disruption
cassette from p5921 (6) was inserted in place of a portion
of ALO1 within the genomic clone (see Fig. 2A). The resulting plasmid, pWK202, was cut with ApaI and
SacI to remove the vector and transformed into the
ura3/ura3 C. albicans strain CAI4 (6).
Ura+ transformants were selected on uracil-deficient
medium, and the integration of the cassette into the ALO1
locus was verified by either PCR or Southern blot analysis. Spontaneous
Ura
derivatives of the heterozygous disruptants were
selected on minimal defined medium supplemented with 625 mg of
5-fluoroorotic acid and 30 mg of uridine per liter. This procedure was
repeated to delete the remaining functional allele of ALO1.
alo1/alo1 strain. The occurrence of the desired integration
events in all the transformants was verified by Southern blot analysis.
Measurement of ALO activity and intracellular EASC level.
The activity of ALO was measured spectrophotometrically in 0.2 M
potassium phosphate (pH 6.1), 1 mM EDTA, 50 mM
D-arabinono-1,4-lactone, and an aliquot of enzyme. The
production of EASC (
265 = 13,150 M
1 · cm
1) was monitored by the
increase in the absorbance at 265 nm during the first 1 min of the
reaction at 36°C. One unit of the enzyme was defined as the amount of
enzyme that produced 1 µmol of EASC per min. The lower limit for
assay of ALO activity was 0.1 mU · mg of protein
1.
1. The lower limit for detection of EASC was 0.1 nmol · g (wet wt) of cells
1.
Assay of resistance to oxidative stress.
The susceptibility
of the cells to H2O2 and menadione was measured
as described previously (10), with some modifications. Cells were grown in minimal defined medium to mid-logarithmic phase
(5 × 106 cells · ml
1),
harvested, and resuspended in 0.1 M potassium phosphate buffer, pH 7.0, to obtain an initial optical density at 600 nm of 0.1. To observe the
sensitivity of the cells to oxidants, various concentrations of
H2O2 or menadione were added to the cell
suspensions. After incubation for 1 h at 30°C, aliquots were
taken from the cell suspensions, diluted appropriately in the same
buffer, and plated onto solid minimal defined medium. Colonies were
counted after incubation for 3 days at 28°C.
Assay of C. albicans virulence. Inbred female BALB/c mice (Seoul National University Laboratory Animal Center) weighing between 18 and 20 g were used for testing the virulence of C. albicans strains according to the method described previously (23). Statistical analyses of the differences in survival between paired groups were performed with the Kaplan-Meier log-rank test. A P value of 0.05 was taken to indicate statistical significance.
Nucleotide sequence accession number. The nucleotide sequence data of the ALO1 gene have been deposited in the GenBank/EMBL/DDBJ database under accession no. AF031228.
| |
RESULTS |
|---|
|
|
|---|
Isolation and characterization of ALO1, which encodes
ALO in C. albicans.
From the comparison of the
predicted amino acid sequence of rat L-gulono-1,4-lactone
oxidase (17) and that of S. cerevisiae ALO
(10), two highly conserved regions were identified. PCR using the oligonucleotide primer pair corresponding to residues 52 to
58 (VGSGHSP) and 444 to 450 (GGKPHWA) of S. cerevisiae ALO could amplify a DNA fragment of 1,359 bp from the chromosomal DNA
of C. albicans ATCC 10231. When cloned and sequenced, the fragment showed a high degree of amino acid sequence similarity to
S. cerevisiae ALO upon BLAST searches of the GenBank
database. The cloned PCR product was used as a probe to screen the
EMBL3 genomic library of C. albicans. From positive
clones, the common 3.8-kb HindIII fragment was subcloned in
pGEM-7Zf(+) and sequenced.
-[N(1)-histidyl]FAD or
8
-[N(3)-histidyl]FAD linkage. Kenney et al.
(12) reported that S. cerevisiae ALO contains a
covalently bound FAD linked to the N(1) position of histidine. In case of C. albicans ALO, however, FAD proved
to be covalently linked to the N(3) position of histidine
(S.-T. Kim, W.-K. Huh, and S.-O. Kang, unpublished data). Based on
these facts, we suggest that the region of amino acid residues 29 to 62 is the covalent FAD-binding site and that the histidine at position 62 is the amino acid covalently linked to FAD in C. albicans ALO.
|
Disruption and overexpression of C. albicans ALO1.
For the gene disruption, a disruption construct was prepared by
replacing a portion of the coding region of ALO1 with the hisG-URA3-hisG sequence (Fig.
2A) and used to transform the
ura3/ura3 C. albicans strain CAI4. The resulting
Ura+ transformants were screened by PCR or Southern blot
analysis, and the spontaneous Ura
"pop-out"
revertants from them were selected on minimal defined medium containing
5-fluoroorotic acid. A homozygous disruption of ALO1 was
generated by repeating the above procedure and confirmed by Southern
blot analysis (Fig. 2B). The alo1/alo1 mutants did not show
any auxotrophy and grew normally in minimal defined medium as well as
in complex medium. They also showed normal growth patterns when grown
in the media with nonfermentable carbon sources such as ethanol and
glycerol. In order to overexpress ALO in C. albicans, we
constructed the plasmid pWK203 by inserting the entire ALO1 gene and its flanking sequences into the plasmid pRC2312, as described in Materials and Methods. C. albicans cells were transformed
with the parental plasmid pRC2312 or pWK203, and transformants
containing either plasmid were selected by plating on uracil-deficient
medium. As originally reported by Cannon et al. (2),
transformation with either pRC2312 or pWK203 resulted in small,
slow-growing colonies at high frequency and larger, fast-growing
colonies at a lower frequency. According to Cannon et al.
(2), the small colonies are replicative transformants with
a plasmid copy number of 2 or 3 per genome, and the larger colonies are
integrative transformants, with the copy number of the integrated
sequence being estimated to be 7 to 12 per diploid genome. For further experiments, we selected the larger, fast-growing colonies.
|
|
Effect of EASC on resistance to oxidative stress.
We tested
whether disruption or overexpression of ALO1 affects the
survival of the cells under oxidative stress conditions. For this
purpose, exponentially growing cells were treated with various
concentrations of H2O2 or menadione, a
redox-cycling agent, and the viable cells were counted. As shown in
Fig. 3A, the alo1/alo1 mutant
strain WH203, which is devoid of EASC, was more sensitive to
H2O2 and menadione than the parental wild-type
strain SC5314, and the susceptibility of WH207 to oxidative stress was
intermediate. When WH206 with a high EASC content was challenged with
the same oxidants, it showed increased resistance to oxidative stress
compared with the control strain WH205 (Fig. 3B). These results
indicate that EASC functions as an important antioxidant in C. albicans. However, disruption or overexpression of ALO1
did not affect the cell survival under other stress conditions, e.g.,
heat shock (40°C for 30 min) or osmotic shock (1 M NaCl).
|
Effect of EASC on hyphal growth of C. albicans.
To
investigate the effect of the alo1 mutation on hyphal growth
of C. albicans, isogenic Ura+ prototrophs
were grown on liquid and solid media that induce hyphal growth, e.g.,
20% serum, Lee's medium (21), Spider medium (22), corn meal agar (Difco), and RPMI 1640 (Gibco BRL).
When grown on solid Spider medium, the parental wild-type strain SC5314 formed extensive agar-invasive hyphae after 3 days (Fig.
4). The Ura+
alo1/ALO1 heterozygote strain WH201 showed a slight
reduction in the extent of hyphal formation. The Ura+
alo1/alo1 strain WH203 showed little hyphal formation
compared with SC5314. The hyphal growth of the ALO1
reintegrant strain WH207 was similar to that of WH201, regaining the
ability to form extensive hyphae. Growth on corn meal agar gave similar
results (Fig. 4). These results indicate that EASC contributes to the hyphal growth of C. albicans. However, in spite of the
defective hyphal growth of WH203 on solid Spider medium and corn meal
agar, the mutant strain exhibited hyphal growth patterns little
different from SC5314 in other liquid and solid media, suggesting that
EASC is not needed for hyphal growth of C. albicans under
all inducing conditions.
|
Virulence studies in a mouse model.
To test the effect of EASC
deficiency on the virulence of C. albicans in a mouse model,
the wild-type strain SC5314, the alo1/alo1 mutant strain
WH203, and the ALO1 reintegrant strain WH207 were intravenously injected into immunocompetent mice. Since the
ura3/ura3 mutants show decreased virulence, isogenic
Ura+ prototrophs were used to infect mice. As illustrated
in Fig. 5, all the mice injected with
SC5314 died within 10 days after infection. In contrast, 40% of the
mice injected with the EASC-deficient strain WH203 survived to the end
of the experiment. The survival difference between SC5314 and WH203 was
significant (P < 0.001 by the Kaplan-Meier log-rank
test). The ALO1 reintegrant strain WH207 was more virulent
than WH203 (P < 0.05 by the Kaplan-Meier log-rank
test). These results indicate that EASC contributes to the virulence of
C. albicans in a mouse model of intravenous infection.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, the ALO1 gene, which encodes the enzyme (ALO) that catalyzes the final reaction of EASC biosynthesis, was identified and cloned in C. albicans. The ALO1 gene is 1,671 bp in size and encodes 557 amino acids with a calculated molecular mass of 63,428 Da, which is comparable to the molecular mass of the enzyme purified from the mitochondrial fraction of C. albicans (66.7 kDa) (9). The results of sequence comparisons show that C. albicans ALO is more similar to L-gulono-1,4-lactone oxidase from animals than to L-galactono-1,4-lactone dehydrogenase from plants, which has also been suggested by investigating the substrate specificity of C. albicans ALO (9). Through disruption of ALO1, we could obtain C. albicans strains devoid of EASC. Also, we could make C. albicans strains with high intracellular levels of EASC by overexpression of ALO1. The alo1/alo1 mutant strain was more sensitive to oxidative stress, and the strain carrying ALO1 on a multicopy plasmid showed a significant increase in survival under oxidative stress compared with the control strain. In S. cerevisiae, EASC has been reported to function as an important antioxidant (10), like ASC in higher animals and plants. The present study shows that it still holds true for C. albicans.
The alo1/alo1 mutants show defective hyphal growth on solid Spider medium and corn meal agar, although not under all inducing conditions. Conditional defects in hyphal growth have been already observed in some other mutants, e.g., the cph1/cph1 (22) and the int1/int1 mutants (8). It is rather interesting that EASC affects the hyphal growth of C. albicans under some conditions. Some possibilities can be suggested: EASC may be required for proper operation of the components in a signal transduction pathway involved in the transition from yeast-like growth to hyphal growth, or a strong reductant activity of EASC may be needed in constituting normal cell wall structure in hyphal growth. It remains to be determined how EASC deficiency causes defective hyphal growth of C. albicans.
C. albicans is a member of the normal microbial flora and does not usually cause disease in immunocompetent hosts. However, C. albicans causes serious diseases in immunocompromised hosts such as leukemic, diabetic, organ transplant, and human immunodeficiency virus-infected patients. Elimination of C. albicans from an infected host requires the cooperation of many immune cells and several candidacidal mechanisms, among which oxygen-dependent killing mechanisms, mediated by a superoxide anion radical myeloperoxidase-H2O2-halide system, and reactive nitrogen intermediates, are crucial (37). Therefore, antioxidant defense systems are assumed to be essential for C. albicans to resist the host immune response and exhibit full virulence. In accordance with this view, exogenous antioxidants impair killing of C. albicans by neutrophils (38) and a catalase-deficient C. albicans strain is far less virulent for mice than the parental wild-type strain (40). The present study shows that the EASC-deficient alo1/alo1 mutant strain exhibits attenuated virulence. These results, taken together with the proved function of EASC as an important antioxidant molecule in C. albicans, suggest that EASC may be essential for C. albicans to stand against the oxidant-mediated killing actions of the host immune system.
Nevertheless, there is a possibility that attenuated virulence of the alo1/alo1 strain may be attributed to its defective hyphal growth, considering the well-established fact that the transition from yeast-like to hyphal growth is important to C. albicans virulence (23). However, this possibility does not seem to be acceptable for the following reasons. (i) Although the alo1/alo1 strain exhibits suppressed hyphal growth on solid Spider medium and corn meal agar, it shows no difference from the wild-type strain when cultured on other media, including the one containing serum. This result strongly suggests that, when inoculated into the vein of a mouse, the alo1/alo1 strain will show a normal transition from yeast-like to hyphal growth. (ii) The cph1/cph1 strain shows defective hyphal formation similar to that of the alo1/alo1 strain but does not suffer any damage in its virulence for mice (23). Therefore, it is not likely that attenuated virulence of the alo1/alo1 strain is attributed to its defective hyphal growth.
The overall virulence of C. albicans can be defined as the sum of survivability and virulence. The former indicates the ability of C. albicans to defend itself against the host immune system and to grow in the host successfully. The latter allows C. albicans to adhere to and penetrate the host tissues and cause the symptoms of disease. Up to now, most studies on C. albicans have been focused on its virulence traits, including adhesion to the host tissues, secretion of proteases, and reversible morphological transitions between yeasts, pseudohyphae, and hyphae. The present study shows that EASC functions as an important antioxidant and is essential for C. albicans to exhibit full virulence, presumably by enhancing survival of the organism in the host. Therefore, we suggest that EASC can be regarded as an important virulence factor and that closer investigation of the defense mechanisms against the host immune system will broaden our understanding of the pathogenicity of C. albicans.
| |
ACKNOWLEDGMENTS |
|---|
We thank William A. Fonzi for providing strain CAI4 and plasmid p5921, Richard D. Cannon for plasmid pRC2312, and Gerald R. Fink for strains JKC19 and HLC52.
This work was supported by a grant of the Korea Health 21 R & D Project, Ministry of Health & Welfare, Republic of Korea (HMP-00-B-20200-0010), and by Research Fellowship of the BK21 project.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Biophysics, School of Biological Sciences, and Institute of Microbiology, Seoul National University, Seoul 151-742, Republic of Korea. Phone: (82) (2) 880 6703. Fax: (82) (2) 888 4911. E-mail: kangsaou{at}plaza.snu.ac.kr.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Burns, J. J. 1957. Missing step in man, monkey and guinea pig required for the biosynthesis of L-ascorbic acid. Nature 180:533[CrossRef]. |
| 2. | Cannon, R. D., H. F. Jenkinson, and M. G. Shepherd. 1992. Cloning and expression of Candida albicans ADE2 and proteinase genes on a replicative plasmid in C. albicans and in Saccharomyces cerevisiae. Mol. Gen. Genet. 235:453-457[CrossRef][Medline]. |
| 3. |
Chatterjee, I. B.
1973.
Evolution and the biosynthesis of ascorbic acid.
Science
182:1271-1272 |
| 4. | Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218[CrossRef][Medline]. |
| 5. | Dumbrava, V.-A., and M. L. Pall. 1987. Control of nucleotide and erythroascorbic acid pools by cyclic AMP in Neurospora crassa. Biochim. Biophys. Acta 926:331-338[Medline]. |
| 6. | Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728[Abstract]. |
| 7. | Fraaije, M. W., W. J. van Berkel, J. A. Benen, J. Visser, and A. Mattevi. 1998. A novel oxidoreductase family sharing a conserved FAD-binding domain. Trends Biochem. Sci. 23:206-207[CrossRef][Medline]. |
| 8. |
Gale, C. A.,
C. M. Bendel,
M. McClellan,
M. Hauser,
J. M. Becker,
J. Berman, and M. K. Hostetter.
1998.
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.
Science
279:1355-1358 |
| 9. | Huh, W.-K., S.-T. Kim, K.-S. Yang, Y.-J. Seok, Y. C. Hah, and S.-O. Kang. 1994. Characterisation of D-arabinono-1,4-lactone oxidase from Candida albicans ATCC 10231. Eur. J. Biochem. 225:1073-1079[Medline]. |
| 10. | Huh, W.-K., B.-H. Lee, S.-T. Kim, Y.-R. Kim, G.-E. Rhie, Y.-W. Baek, C.-S. Hwang, J.-S. Lee, and S.-O. Kang. 1998. D-Erythroascorbic acid is an important antioxidant molecule in Saccharomyces cerevisiae. Mol. Microbiol. 30:895-903[CrossRef][Medline]. |
| 11. |
Imai, T.,
S. Karita,
G. Shiratori,
M. Hattori,
T. Nunome,
K. Ôba, and M. Hirai.
1998.
L-Galactono- -lactone dehydrogenase from sweet potato: purification and cDNA sequence analysis.
Plant Cell Physiol.
39:1350-1358 |
| 12. | Kenney, W. C., D. E. Edmondson, T. P. Singer, M. Nishikimi, E. Noguchi, and K. Yagi. 1979. Identification of the covalently-bound flavin of L-galactonolactone oxidase from yeast. FEBS Lett. 97:40-42[CrossRef][Medline]. |
| 13. | Kim, S.-T., W.-K. Huh, J.-Y. Kim, S.-W. Hwang, and S.-O. Kang. 1996. D-Arabinose dehydrogenase and biosynthesis of erythroascorbic acid in Candida albicans. Biochim. Biophys. Acta. 1297:1-8[CrossRef][Medline]. |
| 14. | Kim, S.-T., W.-K. Huh, B.-H. Lee, and S.-O. Kang. 1998. D-Arabinose dehydrogenase and its gene from Saccharomyces cerevisiae. Biochim. Biophys. Acta 1429:29-39[CrossRef][Medline]. |
| 15. | Kiuchi, K., M. Nishikimi, and K. Yagi. 1982. Purification and characterization of L-gulonolactone oxidase from chicken kidney microsomes. Biochemistry 21:5076-5082[CrossRef][Medline]. |
| 16. |
Köhler, J. R., and G. R. Fink.
1996.
Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development.
Proc. Natl. Acad. Sci. USA
93:13223-13228 |
| 17. |
Koshizaka, T.,
M. Nishikimi,
T. Ozawa, and K. Yagi.
1988.
Isolation and sequence analysis of a complementary DNA encoding rat liver L-gulono- -lactone oxidase, a key enzyme for L-ascorbic acid biosynthesis.
J. Biol. Chem.
263:1619-1621 |
| 18. | Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132[CrossRef][Medline]. |
| 19. |
Leberer, E.,
D. Harcus,
I. D. Broadbent,
K. L. Clark,
D. Dignard,
K. Ziegelbauer,
A. Schmidt,
N. A. Gow,
A. J. P. Brown, and D. Y. Thomas.
1996.
Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans.
Proc. Natl. Acad. Sci. USA
93:13217-13222 |
| 20. |
Lee, B.-H.,
W.-K. Huh,
S.-T. Kim,
J.-S. Lee, and S.-O. Kang.
1999.
Bacterial production of D-erythroascorbic acid and L-ascorbic acid through functional expression of Saccharomyces cerevisiae D-arabinono-1,4-lactone oxidase in Escherichia coli.
Appl. Environ. Microbiol.
65:4685-4687 |
| 21. | Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153[Medline]. |
| 22. |
Liu, H.,
J. Köhler, and G. R. Fink.
1994.
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog.
Science
266:1723-1726 |
| 23. | Lo, H.-J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949[CrossRef][Medline]. |
| 24. | Loewus, F. A., K. Saito, R. K. Suto, and E. Maring. 1995. Conversion of D-arabinose to D-erythroascorbic acid and oxalic acid in Sclerotinia sclerotiorum. Biochem. Biophys. Res. Commun. 212:196-203[CrossRef][Medline]. |
| 25. |
Mapson, L. W., and E. Breslow.
1958.
Biological synthesis of ascorbic acid; L-galactono- -lactone dehydrogenase.
Biochem. J.
68:395-406[Medline].
|
| 26. | Moser, U., and A. Bendich. 1991. Vitamin C, p. 195-232. In L. J. Machlin (ed.), Handbook of vitamins. Marcel Dekker, New York, N.Y. |
| 27. | Murakawa, S., S. Sano, H. Yamashita, and T. Takahashi. 1977. Biosynthesis of D-erythroascorbic acid by Candida. Agric. Biol. Chem. 41:1799-1800. |
| 28. | Nick, J. A., C. T. Leung, and F. A. Loewus. 1986. Isolation and identification of erythroascorbic acid in Saccharomyces cerevisiae and Lypomyces starkeyi. Plant Sci. 46:181-187. |
| 29. |
Nishikimi, M.,
B. Tolbert, and S. Udenfriend.
1976.
Purification and characterization of L-gulono- -lactone oxidase from rat and goat liver.
Arch. Biochem. Biophys.
175:427-435[CrossRef][Medline].
|
| 30. |
Ôba, K.,
S. Ishikawa,
M. Nishikawa,
H. Mizuno, and T. Yamamoto.
1995.
Purification and properties of L-galactono- -lactone dehydrogenase, a key enzyme for ascorbic acid biosynthesis, from sweet potato roots.
J. Biochem. (Tokyo)
117:120-124 |
| 31. |
Østergaard, J.,
G. Persian,
M. W. Davey,
G. Bauw, and M. van Montagu.
1997.
Isolation of a cDNA coding for L-galactono- -lactone dehydrogenase, an enzyme involved in the biosynthesis of ascorbic acid in plants.
J. Biol. Chem.
272:30009-30016 |
| 32. |
Santos, M. A., and M. F. Tuite.
1995.
The CUG codon is decoded in vivo as serine and not leucine in Candida albicans.
Nucleic Acids Res.
23:1481-1486 |
| 33. | Shao, Y.-Y., P. A. Seib, K. J. Kramer, and D. A. van Galen. 1993. Synthesis and properties of D-erythroascorbic acid and its vitamin C activity in the tobacco hornworm (Manduca sexta). J. Agric. Food. Chem. 41:1391-1396[CrossRef]. |
| 34. | Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21[CrossRef][Medline]. |
| 35. |
Staab, J. F.,
S. D. Bradway,
P. L. Fidel, and P. Sundstrom.
1999.
Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwpl.
Science
283:1535-1538 |
| 36. | Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. F. Ernst. 1997. Efglp, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982-1991[CrossRef][Medline]. |
| 37. | Vazquez-Torres, A., and E. Balish. 1997. Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61:170-192[Abstract]. |
| 38. |
Wagner, D. K.,
C. Collins-Lech, and P. G. Sohnle.
1986.
Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chloramines.
Infect. Immun.
51:731-735 |
| 39. | Wheeler, G. L., M. A. Jones, and N. Smirnoff. 1998. The biosynthetic pathway of vitamin C in higher plants. Nature 393:365-369[CrossRef][Medline]. |
| 40. |
Wysong, D. R.,
L. Christin,
A. M. Sugar,
P. W. Robbins, and R. D. Diamond.
1998.
Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.
Infect. Immun.
66:1953-1961 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»